# DXC Technology Co: overview

DXC · NYSE · CIK 1688568 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/dxc.md) · [Financials](/companies/dxc/financials.md) · [Filings](/companies/dxc/filings.md) · [Insiders](/companies/dxc/insiders.md)

Latest reported revenue: [$3.03bn](/filings/0001688568-26-000090.md) for Q2 FY2027, three months to 2026-09-30, from the 10-Q filed Oct 30, 2026 (XBRL us-gaap:Revenues, accession 0001688568-26-000090).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,225](/filings/0001688568-26-000005.md) | [3,169 d](/filings/0001688568-26-000022.md) | [3,159](/filings/0001688568-26-000069.md) | [3,161](/filings/0001688568-26-000090.md) | [3,194](/filings/0001688568-26-000005.md) | [3,130 d](/filings/0001688568-26-000022.md) | [2,999](/filings/0001688568-26-000069.md) | [3,034](/filings/0001688568-26-000090.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [8.9%](/filings/0001688568-26-000005.md) | [7.3% d](/filings/0001688568-26-000022.md) | [6.8%](/filings/0001688568-26-000069.md) | [8.0%](/filings/0001688568-26-000090.md) | [8.2%](/filings/0001688568-26-000005.md) | [7.6% d](/filings/0001688568-26-000022.md) | [5.0%](/filings/0001688568-26-000069.md) | [6.2%](/filings/0001688568-26-000090.md) |
| Net margin | % | [1.8%](/filings/0001688568-26-000005.md) | [8.3% d](/filings/0001688568-26-000022.md) | [0.5%](/filings/0001688568-26-000069.md) | [1.1%](/filings/0001688568-26-000090.md) | [3.4%](/filings/0001688568-26-000005.md) | [(4.5%) d](/filings/0001688568-26-000022.md) | [4.1%](/filings/0001688568-26-000069.md) | [0.8%](/filings/0001688568-26-000090.md) |
| Diluted EPS | $ per share | [0.31](/filings/0001688568-26-000005.md) | not reported | [0.09](/filings/0001688568-26-000069.md) | [0.20](/filings/0001688568-26-000090.md) | [0.61](/filings/0001688568-26-000005.md) | not reported | [0.73](/filings/0001688568-26-000069.md) | [0.15](/filings/0001688568-26-000090.md) |
| Free cash flow | $m | [568 d](/filings/0001688568-26-000005.md) | [238 d](/filings/0001688568-26-000022.md) | [143](/filings/0001688568-26-000069.md) | [365 d](/filings/0001688568-26-000090.md) | [359 d](/filings/0001688568-26-000005.md) | [169 d](/filings/0001688568-26-000022.md) | [359](/filings/0001688568-26-000069.md) | [143 d](/filings/0001688568-26-000090.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [16.3](/filings/0001688568-24-000032.md) | [14.4](/filings/0001688568-25-000029.md) | [13.7](/filings/0001688568-26-000022.md) | [12.9](/filings/0001688568-26-000022.md) | [12.6](/filings/0001688568-26-000022.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [8.5%](/filings/0001688568-24-000032.md) | [7.9%](/filings/0001688568-25-000029.md) | [7.4%](/filings/0001688568-26-000022.md) | [7.9%](/filings/0001688568-26-000022.md) | [7.7%](/filings/0001688568-26-000022.md) |
| Net margin | % | [4.4%](/filings/0001688568-24-000032.md) | [(3.9%)](/filings/0001688568-25-000029.md) | [0.7%](/filings/0001688568-26-000022.md) | [3.0%](/filings/0001688568-26-000022.md) | [0.1%](/filings/0001688568-26-000022.md) |
| Diluted EPS | $ per share | [2.81](/filings/0001688568-24-000032.md) | [(2.48)](/filings/0001688568-25-000029.md) | [0.46](/filings/0001688568-26-000022.md) | [2.10](/filings/0001688568-26-000022.md) | [0.10](/filings/0001688568-26-000022.md) |
| Free cash flow | $bn | [1.2](/filings/0001688568-24-000032.md) | [1.1](/filings/0001688568-25-000029.md) | [1.2](/filings/0001688568-26-000022.md) | [1.2](/filings/0001688568-26-000022.md) | [1.0](/filings/0001688568-26-000022.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dxc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $250.2m | 28,276,735 |  | Added +4,994,936 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $117.1m | 13,233,987 |  | Added +338,736 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $92.4m | 10,436,267 |  | Added +1,361,648 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $71.3m | 8,058,153 |  | Reduced −1,971,813 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $68.0m | 7,683,280 |  | Added +1,536,243 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $64.0m | 7,227,986 |  | Reduced −359,055 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $57.8m | 6,535,424 |  | Added +5,177,418 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $52.5m | 6,025,344 |  | Added +811,146 |
| [Nykredit A/S](/funds/1847328.md) | 2026-06-30 | $51.6m | 5,828,244 |  | Not compared |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $51.1m | 5,774,326 |  | Added +3,026,459 |

## Recent filings

[All 886 filings](/companies/dxc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 20:31 ET | [10-Q](/filings/0001688568-26-000090.md) | Quarterly report, period 2026-09-30 | 0001688568-26-000090 |
| 2026-10-29 | 16:17 ET | [8-K](/filings/0001688568-26-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001688568-26-000089 |
| 2026-07-31 | 20:26 ET | [10-Q](/filings/0001688568-26-000069.md) | Quarterly report, period 2026-06-30 | 0001688568-26-000069 |
| 2026-07-30 | 16:31 ET | [8-K](/filings/0001688568-26-000068.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001688568-26-000068 |
| 2026-07-30 | 16:18 ET | [8-K](/filings/0001688568-26-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001688568-26-000067 |
| 2026-07-22 | 16:06 ET | [8-K](/filings/0001688568-26-000058.md) | 5.07 Shareholder vote results | 0001688568-26-000058 |
| 2026-06-11 | 08:31 ET | [8-K](/filings/0001688568-26-000052.md) | 7.01 Regulation FD disclosure | 0001688568-26-000052 |
| 2026-06-04 | 17:00 ET | [DEF 14A](/filings/0001688568-26-000049.md) | Proxy statement, period 2026-03-31 | 0001688568-26-000049 |
| 2026-05-08 | 20:18 ET | [10-K](/filings/0001688568-26-000022.md) | Annual report, period 2026-03-31 | 0001688568-26-000022 |
| 2026-05-07 | 16:20 ET | [8-K](/filings/0001688568-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001688568-26-000020 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001688568-26-000022.md), filed May 8, 2026.

## Forecast league

Q2 FY2027, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/717a5358-584b-4a53-a9de-b7c49148ee84)

## About the filer

- CIK: 1688568
- Tickers: DXC
- Exchange: NYSE
- SIC code: 7374 Services-Computer Processing & Data Preparation
- State of incorporation: NV
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 31, 2026, 02:14 ET. No prices; not investment advice.